BALCHEM CORP (BCPC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 255,467 | 250,519 | 239,940 | 234,081 |
| Cost of sales | 162,354 | 162,351 | 154,579 | 151,087 |
| Gross margin | 93,113 | 88,168 | 85,361 | 82,994 |
| Selling expenses | 19,300 | 16,926 | 15,557 | 18,014 |
| Research and development expenses | 4,300 | 4,662 | 4,329 | 3,854 |
| General and administrative expenses | 18,071 | 15,565 | 17,483 | 15,329 |
| Total operating expenses | 41,671 | 37,153 | 37,369 | 37,197 |
| Earnings from operations | 51,442 | 51,015 | 47,992 | 45,797 |
| Other (income) expense, net | 335 | -151 | -28 | -331 |
| Interest expense, net | -2,766 | -2,924 | -4,071 | -4,240 |
| Total other (income) expenses | -2,431 | -3,075 | -4,099 | -4,571 |
| Earnings before income tax expense | 49,011 | 47,940 | 43,893 | 41,226 |
| Income tax expense | 10,733 | 10,887 | 10,056 | 9,157 |
| Net earnings | 38,278 | 37,053 | 33,837 | 32,069 |
| Net earnings per common share - basic (in dollars per share) | 1.18 | 1.14 | 1.05 | 0.99 |
| Net earnings per common share - diluted (in dollars per share) | 1.17 | 1.13 | 1.03 | 0.98 |
| Weighted average common shares - basic (in shares) | 32,354,000 | 32,440,000 | 32,373,000 | 32,310,000 |
| Weighted average common shares - diluted (in shares) | 32,682,000 | 32,807,000 | 32,783,000 | 32,649,000 |